Related references
Note: Only part of the references are listed.A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice
Karl Balabanian et al.
BLOOD (2012)
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry
Sarah Beaussant Cohen et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Incidence, Clinical Spectrum, Risk Factors and Impact of HIV-Associated Immune Reconstitution Inflammatory Syndrome in South Africa
Lewis John Haddow et al.
PLOS ONE (2012)
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome
David C. Dale et al.
BLOOD (2011)
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
David H. McDermott et al.
BLOOD (2011)
AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
David H. McDermott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Human Bone Marrow Hosts Polyfunctional Memory CD4+ and CD8+ T Cells with Close Contact to IL-15-Producing Cells
Dietmar Herndler-Brandstetter et al.
JOURNAL OF IMMUNOLOGY (2011)
Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome
Kevin B. Walters et al.
BLOOD (2010)
Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients
Laura Tassone et al.
BLOOD (2010)
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization
M. J. Dugan et al.
BONE MARROW TRANSPLANTATION (2010)
A Pivotal Role for CXCL12 Signaling in HPV-Mediated Transformation of Keratinocytes: Clues to Understanding HPV-Pathogenesis in WHIM Syndrome
Ken Y. C. Chow et al.
CELL HOST & MICROBE (2010)
Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome
Peter J. Mc Guire et al.
CLINICAL IMMUNOLOGY (2010)
WHIM syndrome: congenital immune deficiency disease
Toshinao Kawai et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Professional Memory CD4+ T Lymphocytes Preferentially Reside and Rest in the Bone Marrow
Koji Tokoyoda et al.
IMMUNITY (2009)
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
John F. DiPersio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
Peter J. McCormick et al.
PLOS ONE (2009)
WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4
Toshinao Kawai et al.
BLOOD (2007)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
K Balabanian et al.
BLOOD (2005)
Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency
O Favre et al.
ALLERGY (2005)
Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells
TC Becker et al.
JOURNAL OF IMMUNOLOGY (2005)
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
CW Hendrix et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
CDC Allen et al.
NATURE IMMUNOLOGY (2004)
Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome
AV Gulino et al.
BLOOD (2004)
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
WC Liles et al.
BLOOD (2003)
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
PA Hernandez et al.
NATURE GENETICS (2003)
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers
CW Hendrix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
